<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>EANM&#8217;26 &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/eanm26/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 08 Oct 2026 09:03:57 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>EANM&#8217;26 &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Vienna Prepares for EANM&#8217;26 as Radioactive Drugs Reshape Modern Medicine</title>
		<link>https://bioengineer.org/vienna-prepares-for-eanm26-as-radioactive-drugs-reshape-modern-medicine/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Thu, 08 Oct 2026 09:03:57 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[EANM'26]]></category>
		<category><![CDATA[molecular imaging]]></category>
		<category><![CDATA[nuclear medicine]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[PET]]></category>
		<category><![CDATA[radionuclide therapy]]></category>
		<category><![CDATA[radiopharmaceuticals]]></category>
		<category><![CDATA[theranostics]]></category>
		<category><![CDATA[Vienna]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=407070</guid>

					<description><![CDATA[Around 10,000 experts from 138 countries will gather in Vienna from October 17 to 21, 2026, for EANM'26 as theranostics, artificial intelligence, and expanding clinical applications drive rapid growth in nuclear medicine.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">407070</post-id>	</item>
	</channel>
</rss>
